Ultralife Corporation
NASDAQ:ULBIElectrical Equipment & Parts
+$0.08 today
- Market cap
- $261.13M
- Beta
- 0.76
- P/E (TTM)
- -12.9
- EPS (TTM)
- -$0.49
Volume 0.10M
Average 0.05M
ULBI Accounts Payables
Cash effect of the change in amounts owed to suppliers; growing payables preserve cash.
Ultralife CorporationNASDAQ: ULBI
Accounts Payables · Q1 FY2026 · quarter ended Mar 2026
Accounts payables grows, but more slowly than its trailing trend
Q1 FY2026 accounts payables of $6.25M rose 253.7% year over year, behind the +294.4% change in trailing-twelve-month accounts payables. Sequentially, it rose 120.0% from the prior quarter. Over 3 fiscal years it compounded at -16.9% a year.
Context
- Accounts payables amounted to 3.0% of revenue in FY2025, up 2.9 pp from a year earlier.
- Accounts payables increased in 2 of the last 3 fiscal years.
What to watch
Whether quarterly growth recovers from +253.7% toward the trailing-twelve-month pace of +294.4%.
Sources:Cash FlowText generated from reported figures; not investment advice.
Accounts Payables history
USD · from the cash flow
- Latest · FY2025
- 5.78M USD
- Year-over-year change
- +2590.2%
| Period | Period end | Accounts Payables | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 5.78M | +2590.2% |
| FY2024 | 2024-12-31 | 215K | +107.2% |
| FY2023 | 2023-12-31 | (2.97M) | -129.4% |
| FY2022 | 2022-12-31 | 10.09M | +471.9% |
| FY2021 | 2021-12-31 | (2.71M) | — |
Accounts Payables vs competitors
How ULBI compares with its peers on the latest reported figures
- ULBI's LTM Mar 2026 accounts payables of $10.27M is the 2nd largest of the 7 companies compared; the peer median is $965.82K.
- Its year-over-year change of +294.4% is the 2nd highest of 7, against a peer median of +185.2%.
- Accounts payables amounts to 5.5% of revenue for ULBI, versus a peer median of 10.7%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Mar 2026 | $102.72M | +590.8% | +103.5% | 44.7% | |
| LTM Mar 2026 | $10.27M | +294.4% | -16.9% | 5.5% | |
| FY2026 | $7.16M | +160.5% | +37.1% | — | |
| LTM Mar 2026 | $1.02M | +234.3% | +20.2% | 2.4% | |
| LTM Jan 2026 | $911K | +209.9% | — | 26.5% | |
| LTM Mar 2026 | $239K | +4.4% | — | 0.8% | |
| LTM Mar 2026 | $174.96K | +146.2% | — | 10.7% | |
| Peer median (excluding ULBI) | $965.82K | +185.2% | +37.1% | 10.7% | |
Competitors are the stored peer set for ULBI. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Cash Flow Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Net Income | (230K) | (120K) | 7.2M | 6.41M | (5.9M) |
| Depreciation & Amortization | 3.54M | 4.46M | 3.91M | 4.16M | 5.5M |
| Deferred Income Tax | (147K) | (962K) | 1.3M | 1.23M | (2.54M) |
| Stock-Based Compensation | 671K | 776K | 528K | 698K | 935K |
| Change in Working Capital | 388K | (5.45M) | (11.04M) | 3.89M | 602K |
| Accounts Receivables | 4.42M | (7.88M) | (3.89M) | 7.6M | (4.35M) |
| Inventory | (1.3M) | (8.75M) | (943K) | (109K) | (2.35M) |
| Accounts Payables | (2.71M) | 10.09M | (2.97M) | 215K | 5.78M |
| Other Working Capital | (27K) | 1.09M | (3.24M) | (3.82M) | 1.52M |
| Other Non-Cash Items | 104K | 36K | 33K | 253K | 12.39M |
| Operating Cash Flow | 4.33M | (1.26M) | 1.93M | 16.64M | 10.99M |
| Capital Expenditures | (2.81M) | (1.68M) | (2.55M) | (1.93M) | (3.87M) |
| Acquisitions (Net) | (23.52M) | 0 | 0 | (48.02M) | 0 |
| Purchases of Investments | 0 | 0 | 0 | 0 | 0 |
| Sales of Investments | 0 | 0 | 0 | 0 | 0 |
| Other Investing Activities | 0 | 0 | 0 | 0 | 0 |
| Investing Cash Flow | (26.33M) | (1.68M) | (2.55M) | (49.95M) | (3.87M) |
| Debt Repayment | 19.51M | 517K | 4.25M | 29.25M | (4.75M) |
| Common Stock Issued | 398K | 116K | 1.25M | 2M | 98K |
| Common Stock Repurchased | (148K) | (15K) | (8K) | 0 | 0 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities | (262K) | (115K) | 1.25M | (1.39M) | (24K) |
| Financing Cash Flow | 19.64M | 518K | 5.49M | 29.86M | (4.68M) |
| Effect of Forex Changes | 126K | (276K) | (302K) | 34K | 49K |
| Net Change in Cash | (2.24M) | (2.7M) | 4.57M | (3.42M) | 2.49M |
| Free Cash Flow | 1.51M | (2.94M) | (623K) | 14.7M | 7.12M |
Ultralife Corporation
NASDAQ:ULBI
Intrinsic Alpha fair value
Locked
Current Price
$15.67
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.